Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-LGL Lymphoproliferative Disorders”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Ended earlyNCT00278265
What this trial is testing

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic Leukemia
German CLL Study Group 12
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT07019766
What this trial is testing

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 9,999
Testing effectiveness (Phase 2)Ended earlyNCT00360776
What this trial is testing

Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia

Who this might be right for
Stage III Chronic Lymphocytic LeukemiaStage IV Chronic Lymphocytic LeukemiaT-cell Large Granular Lymphocyte Leukemia
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT01191749
What this trial is testing

Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00363779
What this trial is testing

Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia

Who this might be right for
Large Granular Lymphocytic LeukemiaLGL Leukemia
National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00001533
What this trial is testing

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

Who this might be right for
AnemiaLeukemia, T-CellLymphocytosis+2 more
National Heart, Lung, and Blood Institute (NHLBI) 25
Testing effectiveness (Phase 2)Study completedNCT00345345
What this trial is testing

Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

Who this might be right for
T-LGL Lymphoproliferative Disorders
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT06530550
What this trial is testing

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 51
Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Early research (Phase 1)Study completedNCT02512497
What this trial is testing

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Who this might be right for
Cutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT03239392
What this trial is testing

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

Who this might be right for
LGL LeukemiaCTCL
Bioniz Therapeutics 50
Testing effectiveness (Phase 2)Ended earlyNCT00003910
What this trial is testing

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 59
Large-scale testing (Phase 3)UnknownNCT04453345
What this trial is testing

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Who this might be right for
T-LGL LeukemiaClpd-Nk
Institute of Hematology & Blood Diseases Hospital, China 42
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Not applicableLooking for participantsNCT02863692
What this trial is testing

Registry of the German CLL Study Group

Who this might be right for
CLLSLLHCL+5 more
German CLL Study Group 8,000